Specifically, the activation of STING in tumor cells directly induced the mode of death (apoptosis, necrosis, etc.)[66], while also increasing the sensitivity of tumor cells to cytotoxic T lymphocytes (CTLS) and eliminating inhibitory immune cells within TME [67]. The gene discussed is STING1; the disease is neoplasm.